Introduction To Plant Biotechnology

Toyota to Initiate Sustainable Plant Activities

Toyota to Initiate Sustainable Plant Activities

Toyota Motor Corporation has recently announced via its website www.toyota-media.com/euen/ its plan of initiating sustainable plant activities for its production operations. The activities will focus on the role of nature in developing production sites that blend with their natural surroundings.

Toyota wants to develop and operate such production sites with the objective of reducing CO2 through the use of renewable energy including those derived from biomass and natural energy source such as wind and solar power. The automaker also aims to contribute to the local community and to help in conserving the environment by mean so planting trees and plants. It also wants to achieve a groundbreaking environmental performance through introduction of innovative technology and kaizen or improvement activities.

Toyota the producer of high quality Lexus car cover plans to employ its sustainable plant activities at its TMC’s Tsutsumi Plant which manufactures the Prius hybrid vehicle and chosen to pioneer the model sustainable plant. Aside from the cogeneration system that is already in place, the plant will also make use of a 2,000kW photovoltaic generation system which is one of the biggest in current use among the world’s automobile plants.

The press release posted at www.toyota-media.com/euen/ reported that Toyota is planning to paint some of the Tsutsumi’s exterior walls and other surfaces with environment improving photo catalytic paint which is designed to break down air-born nitrogen oxides and sulfur oxides. The paint is said to have the cleansing effect of around 2,000 trees.

An environmental sustainable plant is not complete without the greeneries; Toyota is planning to have trees local to the area planted in the plant. The automaker also intends to use its biotechnology and its afforestation knowledge like for instance covering the ground and walls with NOx-absorbent vegetation. And as part of its plan to contribute to the local community it will open an on-site environmental educational facility for the enjoyment of the general public.

By implementing all of the above environmental plans with the photovoltaic generation as the main focus, Toyota hopes to lessen Tsutsumi’s CO2 emissions by 5 percent which is equivalent to what a 240 hectare tropical rain forest can absorbed.

Toyota Motor is also doing some developments on its Takaoka Plant. The automaker is installing new innovative assembly line which will begin operation soon. Toyota is hoping that the by further streamlining production systems such as Global Body Line and Set Parts System, it will be able to improve its productivity and energy efficiency. Moreover, the automaker is also expecting that with the addition of the a second innovative assembly line at Takaoka in 2009, the plant will be able to reduce CO2 emission by 35 percent.

Joe Ratzkin is an avid fan of anything automotive. This 34-year old bachelor wanted to be a mechanic when he was a kid but changed his mind and became a freelance writer and researcher instead. He is currently based in Chicago, Illinois.

Be the first to comment - What do you think?
Posted by xblackmindx - November 26, 2010 at 4:38 pm

Categories: Introduction To Plant Biotechnology   Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Biopharmaceutical Plants are Focusing more on Botanical Sources

Biopharmaceutical Plants are Focusing more on Botanical Sources

Since long, Biopharmaceutical plants have been dealing with the manufacture of medicines especially salutary proteins from animal tissues. But the therapeutic proteins extracted from animal tissues cannot meet the growing requirements of medicines. And also these medicines have a lot of side-effects. Hence, alternatives for animal tissues are mandatory to be found out.

Latest techniques of Biotechnology have found out the alternatives for animal tissues. Therapeutic proteins can be obtained from plant sources also. Plants hold the potential for large-scale production of restorative proteins for pharmaceutical and industrial uses. The medicines developed are cost-effective also. Genetically engineered plants can be used to produce curative proteins such as blood product substitutes, mammalian antibodies, hormones, vaccines, cytokines and large number of other therapeutic proteins.

Biopharmaceutical plants use the concepts of Genomics. This needs proper host plant selection and gene expression system. The process of genomics mainly includes introduction of DNA of the target into the proper host plant. This in turn reproduces the target molecule during its growth. For recovery and purification process also, proteins are extracted from plant sources. According to the various reports, this production system is highly efficient and commercially attractive.

Pharmaceutical products developed from plant sources are at their initial stages of development. But according to several investigations, it has the potential to fight with the existing methods. It has additional benefits such as low investment cost, easy purification and recovery, safe production process and large scale production. Hence, Biopharmaceutical plants are focusing more and more on the use of botanical sources instead of animal sources.

 

For more information on Biopharmaceutical plants and the benefits of Biopharmaceutical plants please visit the mentioned website

Be the first to comment - What do you think?
Posted by xblackmindx - November 20, 2010 at 1:39 pm

Categories: Introduction To Plant Biotechnology   Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Biopharmaceutical Plants using latest technologies

Biopharmaceutical Plants using latest technologies

Biopharmaceutical Plants using latest technologies. Latest techniques of Biotechnology have found out the alternatives for animal tissues. Therapeutic proteins can be obtained from plant sources also. Plants hold the potential for large-scale production of restorative proteins for pharmaceutical and industrial uses. The medicines developed are cost-effective also. Genetically engineered plants can be used to produce curative proteins such as blood product substitutes, mammalian antibodies, hormones, vaccines, cytokines and large number of other therapeutic proteins.

Biopharmaceutical plants use the concepts of Genomics. This needs proper host plant selection and gene expression system. The process of genomics mainly includes introduction of DNA of the target into the proper host plant. This in turn reproduces the target molecule during its growth. For recovery and purification process also, proteins are extracted from plant sources. According to the various reports, this production system is highly efficient and commercially attractive.

Pharmaceutical products developed from plant sources are at their initial stages of development. But according to several investigations, it has the potential to fight with the existing methods. It has additional benefits such as low investment cost, easy purification and recovery, safe production process and large scale production. Hence, Biopharmaceutical plants are focusing more and more on the use of botanical sources instead of animal sources.

Hence we can say that biopharmaceutical plants have done a lot for the medical world. These plants are still trying hard to contribute more and more in this field and make the world disease free and reduce the death rate due to several diseases.

 

 

For more information on Pharmaceutical engineering and the benefits of Pharmaceutical engineering and Biopharmaceutical plants please visit the mentioned website

Be the first to comment - What do you think?
Posted by xblackmindx - November 20, 2010 at 7:44 am

Categories: Introduction To Plant Biotechnology   Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

« Previous PageNext Page »